Client of a consultant lobbyist
Moderna Biopharma Canada Corporation
- Meetings this Parliament
- 3
- With MPs
- 0
- Since Nov 2021
- 3
- Active registrations
- 0
Most recent reported meeting: Jul 27, 2026.
Lobbying by Moderna Biopharma Canada Corporation: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
← LobbyingRegistrations in effect
Moderna Biopharma Canada Corporation has no active registration. Organizations must register once paid lobbying passes the legal threshold, and their registration ends when it stops.
Reported meetings
Spreadsheet-
Reported by Jessica Cardill · Consultant
- Jade Mallette · Chief of Staff, Health Canada (HC)
Communicating with government officials about vaccine production, more specifically opportunities to increase biomanufacturing capabilities in Canada.
-
Reported by Jessica Cardill · Consultant
- Sandenga Yeba · Director of Policy & Deputy Chief of Staff, Health Canada (HC)
- Jade Mallette · Chief of Staff, Health Canada (HC)
- Justine Frame · Policy Advisor, Health Canada (HC)
Communicating with government officials about pandemic and emergency planning, including the "Pandemic Preparedness Plan" being prepared by the Public Health Agency of Canada ("PHAC"). Read more
Communicating with government officials about procurement polices and procedures (including, but not limited to, those maintained by the Departments of Health and Public Services and Procurement), more specifically policies and procedures pertaining to the development, procurement and distribution of vaccines, including Moderna's messenger ribonucleic acid ("mRNA") vaccines.
Communicating with government officials about vaccine production, more specifically opportunities to increase biomanufacturing capabilities in Canada.
Communicating with government officials, in general, about pharmaceutical and biotechnology policies, including those related to innovation, research and development and messenger ribonucleic acid ("mRNA") biotechnology.
-
Reported by Jessica Cardill · Consultant
- Mackenzy Metcalfe · Policy Advisor, Finance Canada (FIN)
Communicating with government officials, in general, about pharmaceutical and biotechnology policies, including those related to innovation, research and development and messenger ribonucleic acid ("mRNA") biotechnology. Read more
Communicating with government officials about vaccine production, more specifically opportunities to increase biomanufacturing capabilities in Canada.
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.